{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:19:21Z","timestamp":1791317961430,"version":"4.3.1"},"reference-count":40,"publisher":"The Endocrine Society","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,7,1]]},"DOI":"10.1210\/jc.2007-0393","type":"journal-article","created":{"date-parts":[[2007,5,9]],"date-time":"2007-05-09T02:36:08Z","timestamp":1178678168000},"page":"2552-2558","source":"Crossref","is-referenced-by-count":75,"title":["Beneficial Effects of Eplerenone<i>Versus<\/i>Hydrochlorothiazide on Coronary Circulatory Function in Patients with Diabetes Mellitus"],"prefix":"10.1210","volume":"92","author":[{"given":"Hylton V.","family":"Joffe","sequence":"first","affiliation":[{"name":"Division of Endocrinology, Diabetes, and Hypertension (H.V.J., C.R., K.F., G.K.A.), Department of Medicine, Brigham and Women\u2019s Hospital, Boston, Massachusetts 02115"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond Y.","family":"Kwong","sequence":"additional","affiliation":[{"name":"Divisions of Cardiovascular Division (R.Y.K., M.D.G.-H.), Department of Medicine, Brigham and Women\u2019s Hospital, Boston, Massachusetts 02115"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie D.","family":"Gerhard-Herman","sequence":"additional","affiliation":[{"name":"Divisions of Cardiovascular Division (R.Y.K., M.D.G.-H.), Department of Medicine, Brigham and Women\u2019s Hospital, Boston, Massachusetts 02115"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlin","family":"Rice","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes, and Hypertension (H.V.J., C.R., K.F., G.K.A.), Department of Medicine, Brigham and Women\u2019s Hospital, Boston, Massachusetts 02115"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Feldman","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes, and Hypertension (H.V.J., C.R., K.F., G.K.A.), Department of Medicine, Brigham and Women\u2019s Hospital, Boston, Massachusetts 02115"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gail K.","family":"Adler","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes, and Hypertension (H.V.J., C.R., K.F., G.K.A.), Department of Medicine, Brigham and Women\u2019s Hospital, Boston, Massachusetts 02115"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"key\n\t\t\t\t2019041114003337000_R1","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1161\/01.CIR.0000164232.62768.51","article-title":"Coronary circulatory dysfunction in insulin resistance, impaired glucose tolerance, and type 2 diabetes mellitus.","volume":"111","author":"Prior","year":"2005","journal-title":"Circulation"},{"key":"key\n\t\t\t\t2019041114003337000_R2","doi-asserted-by":"crossref","first-page":"248","DOI":"10.2337\/diab.47.2.248","article-title":"Coronary flow reserve is reduced in young men with IDDM.","volume":"47","author":"Pitkanen","year":"1998","journal-title":"Diabetes"},{"key":"key\n\t\t\t\t2019041114003337000_R3","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1016\/S0735-1097(97)00327-6","article-title":"Reduced myocardial flow reserve in non-insulin-dependent diabetes mellitus.","volume":"30","author":"Yokoyama","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t2019041114003337000_R4","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1161\/01.CIR.0000025404.78001.D8","article-title":"Prognostic value of coronary vascular endothelial dysfunction.","volume":"106","author":"Halcox","year":"2002","journal-title":"Circulation"},{"key":"key\n\t\t\t\t2019041114003337000_R5","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJM199807233390404","article-title":"Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction.","volume":"339","author":"Haffner","year":"1998","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041114003337000_R6","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s00259-003-1388-6","article-title":"Myocardial perfusion in type 2 diabetes with left ventricular hypertrophy: normalisation by acute angiotensin-converting enzyme inhibition.","volume":"31","author":"Hesse","year":"2004","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"key\n\t\t\t\t2019041114003337000_R7","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1007\/s00125-004-1510-8","article-title":"Spironolactone impairs endothelial function and heart rate variability in patients with type 2 diabetes.","volume":"47","author":"Davies","year":"2004","journal-title":"Diabetologia"},{"key":"key\n\t\t\t\t2019041114003337000_R8","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/147323000102900103","article-title":"Aldosterone escape during angiotensin-converting enzyme inhibitor therapy in essential hypertensive patients with left ventricular hypertrophy.","volume":"29","author":"Sato","year":"2001","journal-title":"J Int Med Res"},{"key":"key\n\t\t\t\t2019041114003337000_R9","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1161\/01.HYP.0000044937.95080.E9","article-title":"Effectiveness of aldosterone blockade in patients with diabetic nephropathy.","volume":"41","author":"Sato","year":"2003","journal-title":"Hypertension"},{"key":"key\n\t\t\t\t2019041114003337000_R10","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0895-7061(03)00913-0","article-title":"Aldosterone breakthrough during angiotensin-converting enzyme inhibitor therapy.","volume":"16","author":"Sato","year":"2003","journal-title":"Am J Hypertens"},{"key":"key\n\t\t\t\t2019041114003337000_R11","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041114003337000_R12","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041114003337000_R13","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1161\/01.CIR.0000091405.00772.6E","article-title":"Effects of eplerenone, enalapril, and eplerenone\/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study.","volume":"108","author":"Pitt","year":"2003","journal-title":"Circulation"},{"key":"key\n\t\t\t\t2019041114003337000_R14","doi-asserted-by":"crossref","first-page":"940","DOI":"10.2215\/CJN.00240106","article-title":"Selective aldosterone blockade with eplerenone reduces albuminuria in patients with type 2 diabetes.","volume":"1","author":"Epstein","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"key\n\t\t\t\t2019041114003337000_R15","first-page":"S4","article-title":"Standards of medical care in diabetes","volume-title":"Diabetes Care","year":"2006"},{"key":"key\n\t\t\t\t2019041114003337000_R16","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.2337\/diacare.27.7.1761","article-title":"Tests of glycemia in diabetes.","volume":"27","author":"Goldstein","year":"2004","journal-title":"Diabetes Care"},{"key":"key\n\t\t\t\t2019041114003337000_R17","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1118\/1.598163","article-title":"Magnetic resonance quantification of the myocardial perfusion reserve with a Fermi function model for constrained deconvolution.","volume":"25","author":"Jerosch-Herold","year":"1998","journal-title":"Med Phys"},{"key":"key\n\t\t\t\t2019041114003337000_R18","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1118\/1.1473135","article-title":"Myocardial blood flow quantification with MRI by model-independent deconvolution.","volume":"29","author":"Jerosch-Herold","year":"2002","journal-title":"Med Phys"},{"key":"key\n\t\t\t\t2019041114003337000_R19","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1002\/jmri.20065","article-title":"Analysis of myocardial perfusion MRI.","volume":"19","author":"Jerosch-Herold","year":"2004","journal-title":"J Magn Reson Imaging"},{"key":"key\n\t\t\t\t2019041114003337000_R20","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1161\/01.CIR.101.12.1379","article-title":"Noninvasive detection of myocardial ischemia from perfusion reserve based on cardiovascular magnetic resonance.","volume":"101","author":"Al-Saadi","year":"2000","journal-title":"Circulation"},{"key":"key\n\t\t\t\t2019041114003337000_R21","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/(SICI)1522-2594(199903)41:3<429::AID-MRM1>3.0.CO;2-V","article-title":"Improved contrast agent bolus tracking using T1 FARM.","volume":"41","author":"McKenzie","year":"1999","journal-title":"Magn Reson Med"},{"key":"key\n\t\t\t\t2019041114003337000_R22","doi-asserted-by":"crossref","first-page":"3289","DOI":"10.1161\/CIRCULATIONAHA.105.549170","article-title":"Resting myocardial blood flow is impaired in hibernating myocardium: a magnetic resonance study of quantitative perfusion assessment.","volume":"112","author":"Selvanayagam","year":"2005","journal-title":"Circulation"},{"key":"key\n\t\t\t\t2019041114003337000_R23","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1161\/hc0402.102975","article-title":"Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association.","volume":"105","author":"Cerqueira","year":"2002","journal-title":"Circulation"},{"key":"key\n\t\t\t\t2019041114003337000_R24","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0735-1097(01)01746-6","article-title":"Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force.","volume":"39","author":"Corretti","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t2019041114003337000_R25","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1016\/j.jacc.2004.08.062","article-title":"Noninvasive identification of patients with early coronary atherosclerosis by assessment of digital reactive hyperemia.","volume":"44","author":"Bonetti","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t2019041114003337000_R26","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1136\/hrt.74.3.247","article-title":"Non-invasive measurement of human endothelium dependent arterial responses: accuracy and reproducibility.","volume":"74","author":"Sorensen","year":"1995","journal-title":"Br Heart J"},{"key":"key\n\t\t\t\t2019041114003337000_R27","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","article-title":"The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.","volume":"289","author":"Chobanian","year":"2003","journal-title":"JAMA"},{"key":"key\n\t\t\t\t2019041114003337000_R28","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1097\/00004872-199512010-00061","article-title":"Hydrochlorothiazide exerts no direct vasoactivity in the human forearm.","volume":"13","author":"Pickkers","year":"1995","journal-title":"J Hypertens"},{"key":"key\n\t\t\t\t2019041114003337000_R29","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0895-7061(97)00475-5","article-title":"Effect of antihypertensive treatment on cardiac and subcutaneous artery structure: a comparison between calcium channel blocker and thiazide-based regimens.","volume":"11","author":"Sihm","year":"1998","journal-title":"Am J Hypertens"},{"key":"key\n\t\t\t\t2019041114003337000_R30","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.jacc.2005.09.036","article-title":"Coronary risk factors and myocardial perfusion in asymptomatic adults: the Multi-Ethnic Study of Atherosclerosis (MESA).","volume":"47","author":"Wang","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t2019041114003337000_R31","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1161\/01.ATV.0000132409.87124.60","article-title":"Effect of pravastatin on low-density lipoprotein oxidation and myocardial perfusion in young adults with type 1 diabetes.","volume":"24","author":"Janatuinen","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"key\n\t\t\t\t2019041114003337000_R32","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.2337\/diacare.28.5.1145","article-title":"Effect of a peroxisome proliferator-activated receptor-\u03b3 agonist on myocardial blood flow in type 2 diabetes.","volume":"28","author":"McMahon","year":"2005","journal-title":"Diabetes Care"},{"key":"key\n\t\t\t\t2019041114003337000_R33","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1161\/01.CIR.101.6.594","article-title":"Spironolactone increases nitric oxide bioactivity, improves endothelial vasodilator dysfunction, and suppresses vascular angiotensin I\/angiotensin II conversion in patients with chronic heart failure.","volume":"101","author":"Farquharson","year":"2000","journal-title":"Circulation"},{"key":"key\n\t\t\t\t2019041114003337000_R34","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1042\/cs1030425","article-title":"Aldosterone induces acute endothelial dysfunction in vivo in humans: evidence for an aldosterone-induced vasculopathy.","volume":"103","author":"Farquharson","year":"2002","journal-title":"Clin Sci (Lond)"},{"key":"key\n\t\t\t\t2019041114003337000_R35","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s10741-005-2346-0","article-title":"Effect of aldosterone and mineralocorticoid receptor blockade on vascular inflammation.","volume":"10","author":"Joffe","year":"2005","journal-title":"Heart Fail Rev"},{"key":"key\n\t\t\t\t2019041114003337000_R36","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1161\/01.CIR.103.8.1109","article-title":"Peripheral flow response to transient arterial forearm occlusion does not reflect myocardial perfusion reserve.","volume":"103","author":"Bottcher","year":"2001","journal-title":"Circulation"},{"key":"key\n\t\t\t\t2019041114003337000_R37","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s10545-005-0563-2","article-title":"Impaired myocardial perfusion reserve but preserved peripheral endothelial function in patients with Fabry disease.","volume":"28","author":"Kalliokoski","year":"2005","journal-title":"J Inherit Metab Dis"},{"key":"key\n\t\t\t\t2019041114003337000_R38","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.amjcard.2003.08.074","article-title":"Myocardial perfusion reserve and peripheral endothelial function in patients with idiopathic dilated cardiomyopathy.","volume":"93","author":"Stolen","year":"2004","journal-title":"Am J Cardiol"},{"key":"key\n\t\t\t\t2019041114003337000_R39","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.2337\/diacare.28.9.2106","article-title":"Beneficial effects of adding spironolactone to recommended antihypertensive treatment in diabetic nephropathy: a randomized, double-masked, cross-over study.","volume":"28","author":"Rossing","year":"2005","journal-title":"Diabetes Care"},{"key":"key\n\t\t\t\t2019041114003337000_R40","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1056\/NEJMoa040135","article-title":"Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study.","volume":"351","author":"Juurlink","year":"2004","journal-title":"N Engl J Med"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/92\/7\/2552\/11059267\/jcem2552.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,27]],"date-time":"2019-04-27T19:50:29Z","timestamp":1556394629000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/92\/7\/2552\/2598371"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7,1]]},"references-count":40,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2007,7,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2007-0393","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,7,1]]}}}